10 NYSE Stocks with the Highest Upside Potential

8. Novo Nordisk A/S (NYSE:NVO)

Analyst Upside: 60.19%

Number of Hedge Fund Holders: 60

Novo Nordisk A/S (NYSE:NVO) is one of the top NYSE stocks with the highest upside potential. On August 5, UBS downgraded Novo Nordisk A/S (NYSE:NVO) to Neutral from Buy, bringing the price target down to DKK 340 from DKK 600.

The firm told investors in a research note that it sees “challenging times” for Novo Nordisk A/S (NYSE:NVO), with its analysis showing that the US compounding of weight loss drugs is “here to stay.” UBS added that this brings an uncertain outlook for Novo Nordisk A/S’ (NYSE:NVO) Wegovy.

Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, manufactures, and markets pharmaceutical products.

Its operations are divided into two business segments: biopharmaceuticals and diabetes and obesity care. The latter segment covers GLP-1, insulin, and other protein-related products.